The Food and Drug Administration advisory panel will discuss the Pfizer-BioNTech vaccine only. The proposed dose for children is 10 micrograms, or one-third the adult dose of the Pfizer-BioNTech vaccine.

Moderna on Monday released promising early results for its vaccine in children aged six to 11, but that trial is still ongoing.

Continue reading…

https://www.theguardian.com/us-news/joebiden

160251 total articles

Pin It on Pinterest